Skip to content

Ligand Pharmaceuticals Inc.

LGND Nasdaq SEC CIK 886163

Follow Ligand Pharmaceuticals Weekly email: filings, results, news

News

7 stories filed under Ligand Pharmaceuticals, grouped into ongoing threads

Royalty

Thread · 3 stories

Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book

Deals 20 d ago also on XOMA

Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital

Markets 29 d ago also on XOMA

Ligand Pharmaceuticals at Midwest IDEAS: royalty model gains scale

Markets 29 d ago

More coverage

Ligand Pharmaceuticals CLO Reardon sells $1.43m in stock

Markets 16 d ago

Ligand Pharmaceuticals CFO Octavio Espinoza sells $9.2m in shares

Markets 41 d ago

Ligand Pharmaceuticals Incorporated 2026 Q2 - Results - Earnings Call Presentation

Earnings 49 d ago 2 sources

Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript

Earnings 49 d ago

Next results

NOV6

Q1 2026 results

Friday · estimated from the filing cadence

Profile

Headquarters: SAN DIEGO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 7 stories clustered from the RSS aggregator